Abbott Laboratories Abbott brand CELL-DYN 1800 DILUENT Packaged in 3.8L containers, List Numbers: 99226-01, 08H17-01,(on box), 99226-01, 08H17-02 (on bottle); Product is distributed by Abbott Hematology, 5440 Patrick Henry Dr., Santa Clara, CA 95054 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Abbott brand CELL-DYN 1800 DILUENT Packaged in 3.8L containers, List Numbers: 99226-01, 08H17-01,(on box), 99226-01, 08H17-02 (on bottle); Product is distributed by Abbott Hematology, 5440 Patrick Henry Dr., Santa Clara, CA 95054
Brand
Abbott Laboratories
Lot Codes / Batch Numbers
(List Number On the Box---List Number On the bottle---Lot Number): 99226-01---99229-01---15632I2, 08H17-01---08H17-02---15631I2, 08H17-01---08H17-02---15661I2, 08H17-01---08H17-02---16823I2, 08H17-01---08H17-02---17906I2, 08H17-01---08H17-02---17907I2, 08H17-01---08H17-02---18089I2, 08H17-01---08H17-02---19184I2, 08H17-01---08H17-02---19296I2, 08H17-01---08H17-02---20413I2, 08H17-01---08H17-02---21540I2, 08H17-01---08H17-02---22739I2, 08H17-01---08H17-02---23889I2 Expanded: All lots under recall.
Products Sold
(List Number On the Box---List Number On the bottle---Lot Number): 99226-01---99229-01---15632I2; 08H17-01---08H17-02---15631I2; 08H17-01---08H17-02---15661I2; 08H17-01---08H17-02---16823I2; 08H17-01---08H17-02---17906I2; 08H17-01---08H17-02---17907I2; 08H17-01---08H17-02---18089I2; 08H17-01---08H17-02---19184I2; 08H17-01---08H17-02---19296I2; 08H17-01---08H17-02---20413I2; 08H17-01---08H17-02---21540I2; 08H17-01---08H17-02---22739I2; 08H17-01---08H17-02---23889I2 Expanded: All lots under recall.
Abbott Laboratories is recalling Abbott brand CELL-DYN 1800 DILUENT Packaged in 3.8L containers, List Numbers: 99226-01, 08H17-01,( due to The product failed 12-month stability testing that can lead to falsely reduced hemoglobin (Hgb) test results.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The product failed 12-month stability testing that can lead to falsely reduced hemoglobin (Hgb) test results.
Recommended Action
Per FDA guidance
On September 20, 2005, the firm issued letters to all its direct consignees, informing them of the affected product and providing instructions on the recall. In February, the firm expanded its recall to all lots as a result of having identified an additional failure in a different lot.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
IN, OR
Page updated: Jan 10, 2026